For patients and caregivers

Sjogren’s disease clinical trials

Short answer: our physician practices run sjogren’s disease research studies on a rolling basis, meaning studies open and close throughout the year. This page explains what these studies are like and who they may fit. Whether one is open for you right now depends on the specific study, and the first step is always a conversation, never a commitment.

What is Sjogren’s disease?

Sjogren’s is a condition where the immune system affects moisture-producing glands, causing persistently dry eyes and dry mouth, and often fatigue and joint pain. It is underdiagnosed and, until recently, under-researched, which is exactly why new studies matter.

Who might these studies be for?

People with diagnosed Sjogren’s whose dryness or fatigue significantly affects daily life, and people whose symptoms persist despite current management. Because approved treatment options are limited, research is one of the few paths to newer approaches. One honest boundary: not every person with this condition will qualify, and eligibility always depends on the specific study's criteria.

Is a study open right now?

Studies open and close on a rolling basis, so the honest answer changes month to month. Our rheumatology investigators in the Dallas area include physicians with specific interest and experience in Sjogren’s and related autoimmune conditions. The fastest way to hear when something matches: join the registry once, and a coordinator contacts you when a fitting study opens, typically before public recruitment begins.

What does it cost, and is there compensation?

Study-related visits, exams, and investigational treatment come at no cost to you, and most studies compensate participants for time and travel. Specific compensation depends on the study and is explained clearly before you decide anything.

What happens after you enquire?

A coordinator contacts you, typically within one to two business days, for a plain-language conversation with no commitment attached. If a study fits, a screening visit follows, after an informed consent you can take home first. Participation is voluntary at every step, you can withdraw at any time for any reason, and your regular medical care never depends on your answer. The full walkthrough is in what happens at your first study visit and are clinical trials safe.

Interested, or just curious?

Both are fine. Join the registry, or email patients@stryderesearch.com with your questions; a real person answers.

Join the registry